SILO PHARMA, INC. Increase (Decrease) in Accounts Payable, Trade
SILO PHARMA, INC. (SILO) reported Increase (Decrease) in Accounts Payable, Trade of $12.70 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2013-05-15
- SILO PHARMA, INC. increase (decrease) in accounts payable, trade for the quarter ending 2013-03-31 was $12.70K.
- SILO PHARMA, INC. increase (decrease) in accounts payable, trade for the quarter ending 2012-12-31 was $7.19K.
- SILO PHARMA, INC. increase (decrease) in accounts payable, trade for the quarter ending 2012-09-30 was $8.02K.
- SILO PHARMA, INC. increase (decrease) in accounts payable, trade for the quarter ending 2012-06-30 was $2.77K, a 20.91% decline year-over-year.
- SILO PHARMA, INC. increase (decrease) in accounts payable, trade for fiscal 2012 was $17.97K, a 413.51% increase from fiscal 2011.
- SILO PHARMA, INC. increase (decrease) in accounts payable, trade for fiscal 2011 was $3.50K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month | Increase (Decrease) in Accounts Payable, Trade 18 month | Increase (Decrease) in Accounts Payable, Trade 21 month | Increase (Decrease) in Accounts Payable, Trade 24 month | Increase (Decrease) in Accounts Payable, Trade 27 month | Increase (Decrease) in Accounts Payable, Trade 30 month | Increase (Decrease) in Accounts Payable, Trade 33 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-03-31 | $12.70K 10-Q · filed 2013-05-15 | $19.89K derived: sum of 2 quarters · filed 2013-05-15 | $27.90K derived: sum of 3 quarters · filed 2013-05-15 | $30.67K derived: sum of 4 quarters · filed 2013-05-15 | $34.17K 10-Q · filed 2013-05-15 | |||||
| 2012-12-31 | $7.19K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-05 | $15.21K derived: sum of 2 quarters · filed 2013-03-05 | $17.97K derived: sum of 3 quarters · filed 2013-03-05 | $17.97K 10-K · filed 2013-03-05 | $21.47K 10-K · filed 2013-03-05 | |||||
| 2012-09-30 | $8.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $10.78K derived: sum of 2 quarters · filed 2012-11-13 | $10.78K 10-Q · filed 2012-11-13 | $10.78K derived: sum of 4 quarters · filed 2013-03-05 | $14.28K 10-Q · filed 2012-11-13 | |||||
| 2012-06-30 | $2.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $2.77K 10-Q · filed 2012-08-01 | $2.77K derived: sum of 3 quarters · filed 2013-03-05 | $2.77K derived: sum of 4 quarters · filed 2013-03-05 | $6.27K 10-Q · filed 2012-08-01 | |||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 | $0.00 derived: sum of 2 quarters · filed 2013-03-05 | $0.00 derived: sum of 3 quarters · filed 2013-03-05 | $3.50K derived: sum of 4 quarters · filed 2013-03-05 | $3.50K 10-Q · filed 2012-05-15 | |||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-05 | $0.00 derived: sum of 2 quarters · filed 2013-03-05 | $3.50K derived: sum of 3 quarters · filed 2013-03-05 | $3.50K 10-K · filed 2013-03-05 | $3.50K 10-K · filed 2012-01-26 | |||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $3.50K derived: sum of 2 quarters · filed 2012-11-13 | $3.50K 10-Q · filed 2012-11-13 | |||||||
| 2011-06-30 | $3.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $3.50K 10-Q · filed 2012-08-01 | $3.50K 10-Q · filed 2011-08-15 | |||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | |||||||||
| 2010-12-31 | $0.00 10-K · filed 2012-01-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |